Italy In-vitro Colorectal Cancer Screening Tests Market Size & Outlook
Related Markets
Italy in-vitro colorectal cancer screening tests market highlights
- The Italy in-vitro colorectal cancer screening tests market generated a revenue of USD 46.4 million in 2023 and is expected to reach USD 56.9 million by 2030.
- The Italy market is expected to grow at a CAGR of 3% from 2024 to 2030.
- In terms of segment, fecal occult blood tests was the largest revenue generating test type in 2023.
- Biomarker tests is the most lucrative test type segment registering the fastest growth during the forecast period.
In-vitro colorectal cancer screening tests market data book summary
| Market revenue in 2023 | USD 46.4 million |
| Market revenue in 2030 | USD 56.9 million |
| Growth rate | 3% (CAGR from 2023 to 2030) |
| Largest segment | Fecal occult blood tests |
| Fastest growing segment | Biomarker tests |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fecal Occult Blood Tests, Biomarker tests, CRC DNA Screening Tests |
| Key market players worldwide | Abbott Laboratories, Epigenomics AG, Beckman Coulter, Eiken Chemical Co Ltd, Sysmex Corp, Siemens Healthineers AG ADR, Quest Diagnostics Inc, OncoCyte Corp, Merck KGaA, Kyowa Kirin Co Ltd, R-Biopharm, Immunostics, Randox |
Other key industry trends
- In terms of revenue, Italy accounted for 5.1% of the global in-vitro colorectal cancer screening tests market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany in-vitro colorectal cancer screening tests market is projected to lead the regional market in terms of revenue in 2030.
- Russia is the fastest growing regional market in Europe and is projected to reach USD 53.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Colorectal Cancer Screening Tests Market Scope
In-vitro Colorectal Cancer Screening Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Immunostics | View profile | 51-100 | Ocean City, New Jersey, United States, North America | http://www.immunostics.com/ |
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | http://www.randox.com |
| R-Biopharm | View profile | 501-1000 | Darmstadt, Hessen, Germany, Europe | http://www.r-biopharm.com/ |
| Kyowa Kirin Co Ltd | View profile | 5974 | 1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, Japan, 100-0004 | http://www.kyowa-kirin.com |
| Eiken Chemical Co Ltd | View profile | 1106 | 4-19-9 Taito, Taito-ku, Tokyo, Japan, 110-8408 | http://www.eiken.co.jp |
| Beckman Coulter | View profile | 10001+ | Brea, California, United States, North America | http://www.beckmancoulter.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| OncoCyte Corp | View profile | 46 | 15 Cushing, Irvine, CA, United States, 92618 | https://www.oncocyte.com |
| Epigenomics AG | View profile | 18 | Geneststrasse 5, Berlin, BB, Germany, 10829 | https://www.epigenomics.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Italy in-vitro colorectal cancer screening tests market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro colorectal cancer screening tests market will help companies and investors design strategic landscapes.
Fecal occult blood tests was the largest segment with a revenue share of 81.68% in 2023. Horizon Databook has segmented the Italy in-vitro colorectal cancer screening tests market based on fecal occult blood tests, biomarker tests, crc dna screening tests covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Italy in-vitro colorectal cancer screening tests market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy in-vitro colorectal cancer screening tests market databook
-
Our clientele includes a mix of in-vitro colorectal cancer screening tests market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy in-vitro colorectal cancer screening tests market , including forecasts for subscribers. This country databook contains high-level insights into Italy in-vitro colorectal cancer screening tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy in-vitro colorectal cancer screening tests market size, by test type, 2018-2030 (US$M)
Italy In-vitro Colorectal Cancer Screening Tests Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
